1. Home
  2. VUZI vs HELP Comparison

VUZI vs HELP Comparison

Compare VUZI & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vuzix Corporation

VUZI

Vuzix Corporation

HOLD

Current Price

$4.57

Market Cap

303.5M

Sector

Technology

ML Signal

HOLD

HELP

Cybin Inc. Common Stock

N/A

Current Price

$4.55

Market Cap

279.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VUZI
HELP
Founded
1997
N/A
Country
United States
Canada
Employees
N/A
50
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
303.5M
279.9M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
VUZI
HELP
Price
$4.57
$4.55
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$51.50
AVG Volume (30 Days)
2.7M
694.2K
Earning Date
05-08-2026
07-01-2026
Dividend Yield
N/A
N/A
EPS Growth
61.11
N/A
EPS
N/A
N/A
Revenue
$6,280,611.00
N/A
Revenue This Year
$103.32
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.14
N/A
52 Week Low
$1.83
$4.15
52 Week High
$5.62
$8.55

Technical Indicators

Market Signals
Indicator
VUZI
HELP
Relative Strength Index (RSI) 65.78 43.72
Support Level $2.22 $4.52
Resistance Level $5.62 $6.26
Average True Range (ATR) 0.56 0.26
MACD 0.04 0.01
Stochastic Oscillator 71.81 38.67

Price Performance

Historical Comparison
VUZI
HELP

About VUZI Vuzix Corporation

Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices and third-party original design manufacturer (ODM) and original equipment manufacturer (OEM) devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: